SG/CALL/SARTORIUS STEDIM BIO/295/0.025/21.06.24 Stock

Warrant

881PS

DE000SW1TXB9

Real-time Euronext Paris 08:03:12 2024-05-14 EDT
0.0145 EUR +3.57% Intraday chart for SG/CALL/SARTORIUS STEDIM BIO/295/0.025/21.06.24
Current month-3.45%
1 month-93.33%
Date Price Change
24-05-14 0.0145 +3.57%
24-05-13 0.014 +27.27%
24-05-10 0.011 0.00%
24-05-09 0.011 -24.14%
24-05-08 0.0145 0.00%

Real-time Euronext Paris

Last update May 14, 2024 at 08:03 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer Société Générale Société Générale
881PS
ISINDE000SW1TXB9
Date issued 2023-08-03
Strike 295
Maturity 2024-06-21 (38 Days)
Parity 40 : 1
Emission price 0.88
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.975
Lowest since issue 0.0105
Delta0.03x
Omega 14.80
Premium42.54x
Gearing431.88x
Moneyness 0.7027
Difference Strike 86.2
Difference Strike %+29.22%
Spread 0.016
Spread %80.00%
Theoretical value 0.0120
Implied Volatility 56.52 %
Total Loss Probability 97.75 %
Intrinsic value 0.000000
Present value 0.0120
Break even 295.48 €
Theta-0.01x
Vega0x
Rho0x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
203.6 EUR
Average target price
251.3 EUR
Spread / Average Target
+23.44%
Consensus
  1. Stock Market
  2. Warrants
  3. 881PS Warrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW